A systemic therapy of metastatic renal cancer. A review
Journal Title: Postępy Nauk Medycznych - Year 2011, Vol 24, Issue 2
Abstract
For many years metastatic renal cancer was considered as a chemotherapy-refractory disease. The only two modestly active agents were interleukin 2 and interferon alpha but very few patients benefited from immunotherapy. In recent years, the advances in molecular biology of renal cancer and development of targeted agents have expanded the therapeutic armamentarium. The approved drugs include bevacizumab, sunitinib, sorafenib, temsirolimus, everolimus, and pazopanib. However, relatively many options of possible treatment may sometimes confuse a physician. This paper is a review of the most important clinical trials with the new drugs and an attempt to define the most evidence-based treatment approaches.
Authors and Affiliations
Piotr Potemski
Keywords
Related Articles
- EP ID EP54120
- DOI -
- Views 155
- Downloads 0
Uterine artery embolisation for the treatment of symptomatic uterine fibroids
Introduction. Uterine fibroids are the most common benign uterine tumours which can be treated with conservative, surgery or minimally invasive methods. Selection of patients for embolisation seems to be essential.Aim. A...
Hiperleptynemia u chorych ze świeżym udarem niedokrwiennym mózgu
WstępFakt odkrycia leptyny w 1994 roku, odegrał kluczowe znaczenie w aspekcie nowego postrzegania tkanki tłuszczowej, nie tylko jako rezerwuaru energetycznego ustroju, ale także jako źródła substancji biologicznie czynny...
Heart failure confers a hypercoagulable state and increased blood platelets activity. How to prevent and treat?
Heart failure has long been recognized to predispose to thromboembolic events (including stroke, peripheral, and pulmonary emboli). Poor contractility, low cardiac output, dilated chambers, atrial fibrillation, usually a...
A brief history of the artificial oesophagus
Despite the progress in diagnostics procedures, oesophageal cancer is often diagnosed in its late stages. Because of the advanced stage at which it usually presents, treatment of carcinoma of the oesophagus is just palli...
Leki biologiczne w leczeniu stwardnienia rozsianego. Przegląd aktualnych osiągnięć
Stwardnienie rozsiane należy do schorzeń autoimmunologicznych ośrodkowego układu nerwowego (oun). Powoduje bardzo poważne zmiany w oun, zarówno w sferze ruchowej, czuciowej, jak i w sferze intelektualnej chorych. Jest je...